...
首页> 外文期刊>Open Journal of Clinical Diagnostics >Comparative studies of serum-free media and detection techniques for in vitro drug sensitivity assessment of Plasmodium falciparum
【24h】

Comparative studies of serum-free media and detection techniques for in vitro drug sensitivity assessment of Plasmodium falciparum

机译:无血清培养基和检测技术对恶性疟原虫体外药物敏感性评估的比较研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Malaria continues to be a devastating disease. In a previous study, we formulated a chemically defined culture medium that is able to sustain the complete intraerythrocytic growth of Plasmodium falciparum. We tested the feasibility of using the medium (CDRPMI) as well as human serum-free media enriched with commercially available human-serum substitutes (GFSRPMI and ALBRPMI) to assess the drug sensitivity of P. falciparum, using chloroquine diphosphate (CQ) and dihydroartemisinin (DHART) as conventional antimalarial drugs. Growth inhibition was measured by four different methods: flow cytometry with SYBR Green I (FCM), microscopy (Giemsa method), enzymatic estimation of parasite lactate dehydrogenase (pLDH), and histidine-rich protein 2 (HRPII) determination. In drug sensitivity tests on asynchronous parasites cultured for 96 h in the presence of drugs, the dose-response curves were similar and differences in the 50% growth inhibition concentrations for the drugs, which were estimated by the four methods, were not statistically significant for the three culture media. The effect of the drugs on the growth of synchronous parasites at the ring stage was also assessed in micro-volume tests by three different methods of FCM: tracking fluorescent erythrocytes, schizont test, and merozoite test. Dose-response curves for the drugs were similar, and differences in the 50% growth inhibition concentrations were not statistically significant for CDRPMI and GFSRPMI. Thus CDRPMI as well as GFSRPMI and ALBRPMI can be similarly useful media for drug sensitivity testing of P. falciparum. The FCM, pLDH and HRPII estimations were fast and reliable detection methods, with FCM allowing schizont and merozoite tests to be performed with shorter periods of culture.
机译:疟疾仍然是毁灭性疾病。在先前的研究中,我们配制了一种化学成分确定的培养基,该培养基能够维持恶性疟原虫的完整红细胞内生长。我们测试了使用培养基(CDRPMI)以及富含市售人血清替代品(GFSRPMI和ALBRPMI)的无人血清培养基评估恶性疟原虫药物敏感性的可行性,方法是使用氯喹二磷酸(CQ)和二氢青蒿素(DHART)作为常规抗疟药。通过四种不同方法测量生长抑制:采用SYBR Green I(FCM)的流式细胞术,显微镜(Giemsa方法),寄生虫乳酸脱氢酶(pLDH)的酶促估计和富含组氨酸的蛋白2(HRPII)的测定。在存在药物的情况下培养96 h的异步寄生虫的药物敏感性测试中,剂量反应曲线相似,并且通过四种方法估算的药物生长抑制浓度的50%差异无统计学意义。三种文化媒体。还通过三种不同的FCM方法在微量测试中评估了药物对环形阶段同步寄生虫生长的影响:跟踪荧光红细胞,裂殖体测试和裂殖子测试。药物的剂量反应曲线相似,并且CDRPMI和GFSRPMI的50%生长抑制浓度差异无统计学意义。因此,CDRPMI以及GFSRPMI和ALBRPMI可以类似地用作恶性疟原虫药物敏感性测试的有用介质。 FCM,pLDH和HRPII估计是快速而可靠的检测方法,FCM允许在较短的培养时间内进行裂殖体和裂殖子的检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号